(4S,5S,6R,18R)-5-Hydroxy-3,8,8,15,15,18-hexamethyl-19-oxo-7,9-dioxapentacyclo[11.5.1.0~1,5~.0~6,11~.0~14,16~]nonadeca-2,11-dien-4-yl (2Z)-2-methyl-2-butenoate(CAS: 87980-68-5)
![(4S,5S,6R,18R)-5-Hydroxy-3,8,8,15,15,18-hexamethyl-19-oxo-7,9-dioxapentacyclo[11.5.1.0~1,5~.0~6,11~.0~14,16~]nonadeca-2,11-dien-4-yl (2Z)-2-methyl-2-butenoate (4S,5S,6R,18R)-5-Hydroxy-3,8,8,15,15,18-hexamethyl-19-oxo-7,9-dioxapentacyclo[11.5.1.0~1,5~.0~6,11~.0~14,16~]nonadeca-2,11-dien-4-yl (2Z)-2-methyl-2-butenoate](https://cnstatic.chemtradehub.com/structs/879/87980-68-5-87f4.webp)
CAS号
相关产品
其他供应商提供的 (4S,5S,6R,18R)-5-Hydroxy-3,8,8,15,15,18-hexamethyl-19-oxo-7,9-dioxapentacyclo[11.5.1.0~1,5~.0~6,11~.0~14,16~]nonadeca-2,11-dien-4-yl (2Z)-2-methyl-2-butenoate
基本信息
分子式
C28H38O6
分子量
470.61 g/mol
物理状态
Powder
Physical Properties
密度
1.21±0.1 g/cm3 (20 ºC 760 Torr),
化学标识符
SMILES
C/C=C(/C)\C(=O)O[C@H]1C(=CC23[C@@]1([C@H]4C(=CC(C2=O)C5C(C5(C)C)C[C@H]3C)COC(O4)(C)C)O)C
InChIKey
STFFIQHUWFISBB-RHKHLFRASA-N
数据库引用
MDL号
MFCD28411512
常见问题
巨大戟醇-5,20-缩丙酮-3-当归酸酯为无色结晶性粉末,熔点约为120-122℃。分子量约为614.76。该化合物在有机溶剂中易溶,但在水中几乎不溶。该分子具有较高的反应活性,特别是在酸性条件下容易发生水解反应,释放出当归酸。
该化合物通常通过合成当归酸酯的方法制备,具体步骤为将当归酸酯与巨大戟醇-5,20-缩丙酮进行缩合反应,反应条件为温和的酸性环境,通常使用三氟乙酸作为催化剂。该合成方法具有较高的产率和选择性,产率为70-80%。
该化合物主要应用于医药行业,作为潜在的药物中间体。此外,由于其独特的化学结构,它也可在聚合物合成和功能性材料的研究中作为研究对象。
在处理该化合物时应佩戴适当的个人防护装备(PPE),包括实验服、手套和护目镜。操作应在通风橱中进行,以避免吸入有害气体。若发生泄露,应立即用大量水冲洗,并寻求专业帮助。查阅物质安全数据表(MSDS/SDS)获取更多详细的安全信息。
安全须知
使用前请验证产品规格和安全数据。联系供应商获取详细安全信息。
请始终遵循正确的操作程序



![(3beta,16beta,17alpha,18alpha)-16-Hydroxy-13,28-epoxyolean-11-en-3-yl 6-deoxy-alpha-L-mannopyranosyl-(1->4)-[beta-D-glucopyranosyl-(1->6)]-beta-D-glucopyranoside](https://cnstatic.chemtradehub.com/structs/207/20736-08-7-7c82.webp)
![(4S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione](https://cnstatic.chemtradehub.com/structs/782/78287-27-1-d631.webp)

![(4S,8R,9R,21R)-3,6,6,11,11,18,18,21-Octamethyl-5,7,10,12-tetraoxahexacyclo[14.5.1.0~1,8~.0~4,8~.0~9,14~.0~17,19~]docosa-2,14-dien-22-one](https://cnstatic.chemtradehub.com/structs/775/77573-44-5-d113.webp)
![(1aR,2E,4aR,6S,7S,7aR,8R,11aS)-4a,8-Diacetoxy-1,1,3,6-tetramethyl-9-methylene-4-oxo-1a,4,4a,5,6,7,7a,8,9,10,11,11a-dodecahydro-1H-cyclopenta[a]cyclopropa[f][11]annulen-7-yl benzoate](https://cnstatic.chemtradehub.com/structs/218/218916-52-0-d13e.webp)


![(4S,5S,6R,18R)-5-Hydroxy-3,8,8,15,15,18-hexamethyl-19-oxo-7,9-dioxapentacyclo[11.5.1.0~1,5~.0~6,11~.0~14,16~]nonadeca-2,11-dien-4-yl (2Z)-2-methyl-2-butenoate — 上海绩祥生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce6f4d2b2de6e8e95a45bf/67ce6f4d2b2de6e8e95a45bf-logo.webp)
![(4S,5S,6R,18R)-5-Hydroxy-3,8,8,15,15,18-hexamethyl-19-oxo-7,9-dioxapentacyclo[11.5.1.0~1,5~.0~6,11~.0~14,16~]nonadeca-2,11-dien-4-yl (2Z)-2-methyl-2-butenoate — 北京博奥拓达科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce027457537e5c8069b12f/67ce027457537e5c8069b12f-logo.webp)
![(4S,5S,6R,18R)-5-Hydroxy-3,8,8,15,15,18-hexamethyl-19-oxo-7,9-dioxapentacyclo[11.5.1.0~1,5~.0~6,11~.0~14,16~]nonadeca-2,11-dien-4-yl (2Z)-2-methyl-2-butenoate — 上海源叶生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce9f132b2de6e8e95a48fe/67ce9f132b2de6e8e95a48fe-logo.webp)
![(4S,5S,6R,18R)-5-Hydroxy-3,8,8,15,15,18-hexamethyl-19-oxo-7,9-dioxapentacyclo[11.5.1.0~1,5~.0~6,11~.0~14,16~]nonadeca-2,11-dien-4-yl (2Z)-2-methyl-2-butenoate — 上海吉至生化科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67cecbee2b2de6e8e95a5b72/67cecbee2b2de6e8e95a5b72-logo.webp)
![(4S,5S,6R,18R)-5-Hydroxy-3,8,8,15,15,18-hexamethyl-19-oxo-7,9-dioxapentacyclo[11.5.1.0~1,5~.0~6,11~.0~14,16~]nonadeca-2,11-dien-4-yl (2Z)-2-methyl-2-butenoate — 南京普怡生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67cecda42b2de6e8e95a5fa6/67cecda42b2de6e8e95a5fa6-logo.webp)
![(4S,5S,6R,18R)-5-Hydroxy-3,8,8,15,15,18-hexamethyl-19-oxo-7,9-dioxapentacyclo[11.5.1.0~1,5~.0~6,11~.0~14,16~]nonadeca-2,11-dien-4-yl (2Z)-2-methyl-2-butenoate — 上海诗丹德标准技术服务有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce6c0f2b2de6e8e95a457f/67ce6c0f2b2de6e8e95a457f-logo.webp)